MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.23
-0.01 (-0.81%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,387.8% upside
Low Target
$21.05
Average Target
$30.60
High Target
$40.98
Current Price
$1.23
Current
$1.23
$1.23
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Scenario Analysis
Bear Case
$21.05
1,611.4%
Low target
Base Case
$30.60
+2,387.8%
Avg target
Bull Case
$40.98
+3,231.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.95
-68.9% from high
52-Week Low
$1.13
+8.8% from low
50-Day SMA
$1.24
-0.8% vs SMA
RSI (14)
40.6
Neutral
Target vs 52W High
$30.60
+674.7% vs high
Next Earnings Report
Aug 19, 2026
3d
until earnings
EPS Est: $-0.58
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |